Scientists discover harder-to-detect version of Omicron variant

Australia’s Queensland state has found a new omicron lineage in a traveler who arrived from South Africa, health authorities said Wednesday.

The new lineage has about half the gene variations of the original and can’t be detected with typical screening, the state’s acting chief health officer Peter Aitken told reporters. It was found in a traveler who had arrived from South Africa and tested positive for the coronavirus on Saturday, he said.

The new lineage has enough markers “to be able to classify it as omicron, but we don’t know enough about it as to what that means then as far as clinical severity, vaccine effectiveness,” Aitken said. “We now have omicron and omicron-like.”

The discovery comes as Queensland prepares to finally reopen its border to the rest of Australia ahead of schedule next Monday, as more than 80% of the eligible population will be fully vaccinated later this week.

The discovery may be a setback for scientists racing to understand the full impact of the omicron variant, including how virulent the strain is and whether vaccines are effective at reducing risk of severe disease. Although most genetic changes are innocuous as viruses mutate, some can make the mutant more adept at infecting cells, for example, or evading antibodies.

The new lineage has about half, or 14, of the genome mutations of the conventional omicron variant and doesn’t have the s-gene dropout feature, making it harder to track through PCR testing, Aitken said. The discovery is “going to lead to improvements in people recognizing potential spread of omicron in all communities,” he said.

  • Related Posts

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    New Delhi: Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its generic version of glycerol phenylbutyrate oral liquid…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India